• Exchange: Copenhagen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Bavarian Nordic A/S

+ Add to Watchlist

BAVA:DC

105.0000 DKK 1.5000 1.41%

As of 11:02:19 ET on 04/24/2014.

Snapshot for Bavarian Nordic A/S (BAVA)

Open: 107.0000 Day's Range: 104.0000 - 109.0000 Volume: 161,638
Previous Close: 106.5000 52wk Range: 54.5000 - 110.0000 1-Yr Rtn: -

Stock Chart for BAVA

No chart data available.
  • BAVA:DC 105.0000
  • 1D
  • 1M
  • 1Y
106.5000
Interactive BAVA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BAVA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 179.4872
Relative P/E vs. KFX -
Earnings Per Share (DKK) (ttm) -1.7904
Est. EPS (DKK) (12/2014) 0.5850
Est. PEG Ratio -
Market Cap (M DKK) 2,739.91
Shares Outstanding (M) 26.09
30 Day Average Volume 132,380
Price/Book (mrq) 2.7492
Price/Sale (ttm) 2.2597
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/14/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BAVA

  • Revenue
  • Net Income (M/DKK)
  • Profit Margin (%)

Company Profile & Key Executives for BAVA

Bavarian Nordic A/S is a biotechnology company developing and producing vaccines for the treatment and prevention of cancer and infectious diseases. The company also manufactures and delivers modern smallpox vaccines for governments under national emergency rules.

Gerard W M Van OdijkChairmanAnders HedegaardPresident/CEO
James B Breitmeyer "Jim"Pres:Cancer Vaccine/Exec VPPaul ChaplinPres:Infectious Diseases/Exec VP
More Company Profile & Key Executives for BAVA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil